Abstract
Microencapsulation techniques have been developed and refined for many years. However, in recent years, great strides have been made in controlling the microcapsule size down to the nanometer range when necessary. Progress has also been made in controlling the ratio of wall/capsule and the distribution of microcapsule diameter size in the batching of the capsules.
One area of application for microencapsulation is the convenience of dosing large groups of animals once with a sustained-release dosage form rather than with repeated administration since this involves greater effort at animal management.
For example, targeted dosages can be achieved by a specialized drug delivery system. Since animal systems are varied and ruminant animals have a digestive system that is different from and more complex than that of other animals, oral administration of a drug substance to be retained through the rumen to the abomasum for subsequent dissolution and/or excretion may be affected by a microencapsulation process. Miller and Gordon of USDA achieved this for control of fecal breeding flies by systemic retention of a microencapsulated pesticide drug into the manure.
Perhaps one of the most challenging areas is that of pharmaceuticals. There is now considerable interest in the area of microparticulate drug delivery systems. Examples of how desirable nutritional properties and taste preference are achieved and how these provide improved animal products will be discussed. Additional areas of interest and some possible future systems that have advantages over conventional systems will be discussed.
A brief description of some general requirements by the Food and Drug Administration (FDA) for approval of these drug delivery systems will be presented.
Similar content being viewed by others
References
Bakan, J. A., and Anderson, J. L. (1970), “The Theory and Practice of Industrial Pharmacy,” inMicroencapsulation (L. Lachman, H. A. Liberman, and J. L. Ranig, eds.), pp. 384–407, Lea and Febiger, Philadelphia.
Bell, S. A., Berdick, M., and Holliday, W. M. (1966),J. New Drugs 6, No. 5.
Chang, T. M. S., MacIntosh, F. C., and Mason, S. G. (1966),Can. J. Physiol. Pharmacol. 44, 115.
Luzzi, L. A., Zoglio, M. A., and Maulding, J. V. (1970),J. Pharm. Sci. 59, No. 3, 338.
Luzzi, L. (1970),J. Pharm. Sci. 59, No. 10, 1367.
Phares, R. E., and Sperandio, G. J. (1964),J. Pharm. Sci. 53, No. 5, 515.
Sparks, R. E., (1968), paper presented at Microencapsulation Workshop, Hopatcong, New Jersey, September 1968.
Chang, T. M. S. (1972),Artificial Cells, Charles C Thomas, Springfield, IL.
US Patent 3,577,515, J. E. Vandegaer to Pennwalt Corp.
Miller, R. W. and Gordon, C. H. (1972),Econ. Entomol. 65, 455.
Chem. Eng. News, July 31, 1971, p. 11.
Bitman, J., Dryden, L. P., Goering, H. R., Wrenn, T. R., Yoneos, R. A., Edmonson, K. I., and Edmonson, L. F. (1973),J. Am. Oil Chem. Soc. 50, 93.
Sparks, R. E. (1971), Microencapsulation Course, Sept. 26–28, 1971, Woodbridge, NJ.
Chem. Eng. News, August 12, 1974.
DeSavigny, C. B., and Ivy, E. E. (1974), “Microencapsulated Pesticides,” inMicroencapsulation: Processes and Applications”, Vandegaer, J. E., ed., Plenum, New York.
Quick Frozen Foods Magazine, November 1971.
Speiser, P. (1976), “Microencapsulation by Coacervation, Spray Encapsulation and Nanoencapsulation,” inMicroencapsulation, Nixon, J. R. ed. Dekker, New York.
Abrams, J., and Hinkes, T. M. (1974),Pest Control 42, 14.
Render Magazine, August, 1976.
Chem. Eng. News, June 28, 1976.
Santos, A. (1975), Summary of Results of Laboratory Screening of Compound 443A Against O. Quadrasi Contr. Rel. Mollusci, Newsletter, Univ. of Akron, April pp. 504.
Feedstuffs, March 7, 1977.
Madan, P. L., Jani, P. K., and Bartilucci, A. J. (1978),J. Pharm Sci. 67, (No. 3), 409.
Bureau of Veterinary Medicine Stability Guidelines, February 1, 1978.
Holly, J., and Trescony, P. V. (1979),J. Pharm Sci. 68 (No. 7), 919.
Olandoff, L., and Anderson, J. M. (1979),J. Pharm. Sci. 68 (No. 9), 1147.
Chem. Eng. News, p. 43, Jan. 25, 1982.
Langer, R. (Feb. 1982),Chemtech. 98.
Widder, K., et al. (1979),J. Pharm. Sci. 68, 79.
Sheumaker, J. L. (1983),Microparticulate Drug, Delivery Systems: Microcapsules, Nanoparticles and Liposomes, 18th Arden House Conference, Ind. Pharm. Sec. APhA, Harriman, NY.
Oppenheim, R. C. (ibid) (1983),Microparticulate Drug, Delivery Systems: Microcapsules, Nanoparticles and Liposomes, 18th Arden House Conference, Ind. Pharm. Sec. APhA, Harriman, NY.
Hunt, C. A. (ibid) (1983),Microparticulate Drug, Delivery Systems: Microcapsules, Nanoparticles and Liposomes, 18th Arden House Conference, Ind. Pharm. Sec. APhA, Harriman, NY.
DeLuca, P. P. (ibid) (1983),Microparticulate Drug, Delivery Systems: Microcapsules, Nanoparticles and Liposomes, 18th Arden House Conference, Ind. Pharm. Sec. APhA, Harriman, NY.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arnold, R.G. Microcapsules for new animal drugs. Appl Biochem Biotechnol 10, 237–243 (1984). https://doi.org/10.1007/BF02783755
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02783755